Comparison of intravitreal ranibizumab therapy with and without laser photocoagulation for diabetic macular edema.
Not Applicable
- Conditions
- Diabetic macular edema
- Registration Number
- JPRN-jRCTs031180328
- Lead Sponsor
- Kitano Shigehiko
- Brief Summary
In diabetic macular edema, no significant effect of improving retinal thickness and visual acuity was confirmed in the combination group compared to the single group. In addition, there was no significant difference between the two groups in the number of doses of ranibizumab and the average dosing interval.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
HbA1c under 10 %
CRT over 300 micrometer
BCVA over 0.1
Written informed consent
Exclusion Criteria
Posttreatment for diabetic macular edema within 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual acuity
- Secondary Outcome Measures
Name Time Method Visual acuity and number of treatments